IJVPH

Nasal Form of Transmissible Venereal Tumour: A Case Study
Volume 9 | Issue 1 | December 2022
AUTHOR(S)
Mousumi Namasudra, Rakibul Hoque, Gopal Sarkar, Saktipada Pradhan, Rabindranath Hansda, Samiran Mondal

ABSTRACT

An adult dog was referred for evaluation of right sided unilateral epistaxis and growth at the base of the penis and prenasal area since one month. Upon clinical examination, a multilobular tumorous mass was located on the base of the penile bulb, causing sanguinous discharge. Nasal transmissible venereal tumour (TVT) in dogs is a rare manifestation of a tumour that typically develops from genital or oral lesions. The samples for cytological diagnostics were taken from nasal and preputial growth by FNAB and smears were prepared andstained with Wright’s Giemsa for diagnostic purpose. The findings strongly suggested the presence of high levels of cellularity, tumour cells that were large, rounded cells with round nuclei, coarse and reticulated chromatin, abundant and lightly basophilic cytoplasm, and multiple punctate cytoplasmic vacuoles, all of which were conclusive of the cytological diagnosis of CTVT. The preputial lump was surgically removed, and its histology was evaluated. Cytology procured with histopathology recommended for TVT.

Abeka, Y. T. Review on Canine Transmissible Venereal Tumor (CTVT). Cancer Therapy and Oncology International Journal. 2019; 14(4): 1–9. https://doi.org/10.19080/ctoij.2019.14.555895
Ajayi OL, Oluwabi M, Ajadi RA, Antia RE, Omotainse SO, Jubril AJ, Adebayo OO. Cytomorphological histopathological and immunohistochemical observations on the histiocytic origin of canine transmissible venereal tumour. Sokoto J Vet Sci. 2018; 16: 10-20.
Amber EI, RA Henderson, JB Adeyanju, EO Gyang. Single-drug chemotheraphy of canine transmissible venereal tumour with cyclophosphamide, methotrexate or vincristine. J. Vet. Intern. Med. 1990; 4: 144–147.
Anusha A, Ramana, KV, Reddy KCS. Studies on transmissible venereal tumour ( TVT) in canines. 2022; 11(6): 1544–1547.
Boscos CM, Ververidis HN. 2004. Canine TVT – Clinical Findings, Diagnosis and Treatment. Proceedings of the 29th World Congress of the World Small Animal Veterinary Association. http://www.vin.com/proceedings/Proceedings.plx? CID=WSAVA2004, [accessed 12 April 2023].
Brand~ao C, Borges A, Ranzani J, Rahal SC, Teixeira CR, Rocha NS.Transmissible venereal tumor in dogs: a retrospective study of 127cases (1998–2000). Rev Educ Contin CRMV SP. 2002; 5: 25–31.
Cohen, D. The biological behaviour of the transmissible venereal tumour in immunosuppressed dogs. European Journal of Cancer. 1973; 9(4): 253–258. https://doi.org/10.1016/0014-2964(73)90090-X.
Das U, Das AK. Review of canine transmissible venereal sarcoma. Veterinary Research Communications. 2000; 24: 545–556.
Erunal-Maral N, M Findik, S Aslan. Use of exfoliative cytology for diagnosis of transmissible venereal tumour and controlling the recovery period in the bitch. Dtsch. Tierarztl. Wochenschr. 2000; 107: 175–180.
Filgueira K, Peixoto G, Fonseca Z. Canine TransmissibleVenerealTumor with Multiple Extragenital Locations. ActaSci Vet. 2013; 41:1–6.
Ganguly B, Das U, Das A. Canine transmissible venereal tumour: a review. Vet Comp Oncol. 2016; 14: 1–13. Kabuusu R, Stroup D, Fernandez C. Risk factors and characteristicsof canine transmissible venereal tumours in Grenada, West Indies.Vet Comp Oncol. 2010; 8:50–55.
Melendez-Zajgla J, Maldonado V. Is cancer a ´ transmittable disease? GacetaM´edica de M´exico. 2007; 143: 353–354.
Mukaratirwa S, Gruys E. Canine transmissible venereal tumour: Cytogenetic origin, immunophenotype, and immunobiology. A review. Veterinary Quarterly, 2003; 25(3), 101–111. https://doi.org/10.1080/01652176.2003.9695151
Ogilvie G, LaRue S. Canine and feline nasal and paranasalsinustumors. Vet Clin North Am Small Anim Pract. 1992; 22: 1133–1144.
Papazoglou L, Koutinas A, Plevraki A, Tontis D. Primary intranasal transmissible venereal tumour in the dog: a retrospective study of six spontaneous cases. J Vet Med A Physiol Pathol Clin Med. 2001; 48: 391–400.
Park MS, Kim Y, Kang MS, Oh SY, Cho DY, Shin N, Kim DY. Disseminated transmissible venereal tumour in a dog. Journal of Veterinary Diagnostic Investigation, 2006; 18(1), 130–133. https://doi.org/10.1177/104063870601800123.
Raskin R, Meyer DJ. Canine and feline cytology: a color atlas and interpretation guide. 2nd ed. Missouri: Saunders/Elsevier; 2010.
Rogers KS, MA Walker, HB Dillon. Transmissible venereal tumor: a retrospective study of 29 cases. J. Am. Anim. Hosp. Assoc. 1998; 34: 463–469.
Scarpelli KC, Valladão ML, Metze K. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy. Veterinary Journal. 2010; 183(3), 362–363. https://doi.org/10.1016/j.tvjl.2008;11.009
Setthawongsin C, Tangkawattana S, Rungsipipat A, Techangamsuwan S. Computerized cytomorphometric and cytomorphological analysis of canine transmissible venereal tumours. J Comp Pathol. 2018; 163: 18-22.
Setthawongsin C, Techangamsuwan S, Rungsipipat A. Canine Transmissible Venereal Tumor: An Infectious Neoplasia in Dogs. Intech Open. 2023. https://doi.org/10.5772/intechopen.106150.
Setthawongsin C, Techangamsuwan S, Tangkawattana S, Rungsipipat A. Cell-based polymerase chain reaction for canine transmissible venereal tumor (CTVT) diagnosis. J Vet Med Sci. 2016; 78: 1167-73.

DOI
https://doi.org/10.62418/ijvph.9.1.2022.66-71
How to cite this article:
Corresponding author’s email ID: vetsamiran@gmail.com
Citation: Namasudra M, Hoque R, Sarkar G, Prandhan S, Hansda RN, Mondal S. Nasal Form of Transmissible Venereal Tumour: A Case Study. Indian Journal of Veterinary Public Health. 2022; 9(1): 66-71.
DOI: https://doi.org/10.62418/ijvph.9.1.2022.66-71